Hybio Pharmaceutical Cash Flow-to-Debt Ratio
Hybio Pharmaceutical cash flow-to-debt ratio. Hybio Pharmaceutical (300199) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥117.78 Million could theoretically repay 0% of its total liabilities (CN¥2.50 Billion) in one year. Check 300199 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hybio Pharmaceutical (2007–2024)
Cash flow-to-debt ratio of Hybio Pharmaceutical from 2007 to 2024. Historical debt coverage capacity for Hybio Pharmaceutical across 18 annual periods. Check Hybio Pharmaceutical cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Hybio Pharmaceutical Cash Flow-to-Debt Ratio by Year (2007–2024)
Hybio Pharmaceutical cash flow-to-debt ratio by year from 2007 to 2024. Year-by-year debt coverage analysis for Hybio Pharmaceutical. For the full cash flow conversion analysis, see Hybio Pharmaceutical cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥164.71 Million | CN¥2.41 Billion | ▲ +4917.1% |
| 2023 | 0.00x | CN¥-3.54 Million | CN¥2.49 Billion | ▼ -120.8% |
| 2022 | 0.01x | CN¥15.81 Million | CN¥2.31 Billion | ▼ -90.2% |
| 2021 | 0.07x | CN¥156.83 Million | CN¥2.26 Billion | ▲ +238.9% |
| 2020 | 0.02x | CN¥47.99 Million | CN¥2.34 Billion | ▼ -51.2% |
| 2019 | 0.04x | CN¥104.64 Million | CN¥2.49 Billion | ▲ +102.7% |
| 2018 | 0.02x | CN¥47.00 Million | CN¥2.27 Billion | ▼ -86.3% |
| 2017 | 0.15x | CN¥213.74 Million | CN¥1.41 Billion | ▼ -56.5% |
| 2016 | 0.35x | CN¥296.41 Million | CN¥852.42 Million | ▲ +127.6% |
| 2015 | 0.15x | CN¥138.84 Million | CN¥908.68 Million | ▼ -60.0% |
| 2014 | 0.38x | CN¥153.43 Million | CN¥401.32 Million | ▼ -59.0% |
| 2013 | 0.93x | CN¥153.48 Million | CN¥164.48 Million | ▲ +15.0% |
| 2012 | 0.81x | CN¥87.19 Million | CN¥107.42 Million | ▼ -33.3% |
| 2011 | 1.22x | CN¥72.48 Million | CN¥59.56 Million | ▼ -28.1% |
| 2010 | 1.69x | CN¥54.69 Million | CN¥32.30 Million | ▲ +255.0% |
| 2009 | 0.48x | CN¥26.11 Million | CN¥54.73 Million | ▼ -61.1% |
| 2008 | 1.23x | CN¥45.75 Million | CN¥37.32 Million | ▼ -76.2% |
| 2007 | 5.14x | CN¥49.04 Million | CN¥9.54 Million | — |